loading
Schlusskurs vom Vortag:
$3.34
Offen:
$3.33
24-Stunden-Volumen:
1.75M
Relative Volume:
1.11
Marktkapitalisierung:
$546.81M
Einnahmen:
$400.57M
Nettoeinkommen (Verlust:
$9.21M
KGV:
-0.5695
EPS:
-6.04
Netto-Cashflow:
$146.36M
1W Leistung:
-18.29%
1M Leistung:
-15.69%
6M Leistung:
-47.00%
1J Leistung:
-63.75%
1-Tages-Spanne:
Value
$3.26
$3.50
1-Wochen-Bereich:
Value
$3.26
$4.20
52-Wochen-Spanne:
Value
$3.26
$15.70

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
Firmenname
Ironwood Pharmaceuticals Inc
Name
Telefon
617-621-7722
Name
Adresse
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
Mitarbeiter
267
Name
Twitter
@ironwoodpharma
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
IRWD's Discussions on Twitter

Vergleichen Sie IRWD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
IRWD 3.44 546.81M 400.57M 9.21M 146.36M -6.04
ZTS 176.96 79.84B 9.15B 2.43B 2.31B 4.92
HLN 9.65 43.63B 14.26B 1.55B 0 0.3327
TAK 13.38 42.42B 30.27B 1.93B 3.45B 0.444
TEVA 17.12 19.40B 16.77B -959.00M 1.37B -2.00
VTRS 13.37 15.96B 15.05B -883.30M 1.89B 1.53

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-01-17 Eingeleitet Craig Hallum Buy
2023-12-14 Eingeleitet Wells Fargo Overweight
2023-11-09 Eingeleitet Jefferies Buy
2023-09-28 Eingeleitet JMP Securities Mkt Outperform
2022-09-02 Eingeleitet CapitalOne Overweight
2022-04-22 Eingeleitet Piper Sandler Overweight
2020-09-30 Herabstufung Wells Fargo Overweight → Equal Weight
2020-06-17 Eingeleitet Northland Capital Outperform
2019-07-10 Fortgesetzt Credit Suisse Neutral
2019-03-27 Hochstufung Morgan Stanley Underweight → Equal-Weight
2019-02-25 Hochstufung H.C. Wainwright Sell → Neutral
2019-01-24 Hochstufung JP Morgan Underweight → Neutral
2018-11-07 Herabstufung Credit Suisse Outperform → Neutral
2018-11-07 Herabstufung JP Morgan Neutral → Underweight
2018-07-23 Eingeleitet H.C. Wainwright Sell
2018-05-09 Herabstufung Morgan Stanley Equal-Weight → Underweight
2018-01-05 Herabstufung BofA/Merrill Buy → Underperform
2017-12-06 Herabstufung Mizuho Buy → Neutral
2017-07-21 Herabstufung JP Morgan Overweight → Neutral
2017-05-03 Eingeleitet Wells Fargo Outperform
2017-04-07 Bestätigt Mizuho Buy
2017-02-22 Bestätigt Barclays Equal Weight
2016-11-04 Bestätigt Mizuho Buy
2016-10-24 Bestätigt Wedbush Neutral
2016-10-10 Bestätigt Mizuho Buy
2016-09-27 Bestätigt WallachBeth Hold
Alle ansehen

Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten

pulisher
04:30 AM

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Acquired by KBC Group NV - Defense World

04:30 AM
pulisher
Nov 23, 2024

Principal Financial Group Inc. Has $3.03 Million Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Nov 23, 2024
pulisher
Nov 22, 2024

Pacer Advisors Inc. Grows Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 22, 2024
pulisher
Nov 21, 2024

IRWDIronwood Pharmaceuticals, Inc.Latest Stock News & Market Updates - StockTitan

Nov 21, 2024
pulisher
Nov 21, 2024

Ironwood Pharmaceuticals SVP sells shares for $44,884 - Investing.com India

Nov 21, 2024
pulisher
Nov 21, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Stake Lessened by Sumitomo Mitsui Trust Group Inc. - Defense World

Nov 21, 2024
pulisher
Nov 21, 2024

Ironwood Pharmaceuticals SVP sells shares worth $21,868 By Investing.com - Investing.com South Africa

Nov 21, 2024
pulisher
Nov 20, 2024

Ironwood Pharmaceuticals SVP sells shares worth $21,868 - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Ironwood Pharmaceuticals SVP sells shares for $44,884 By Investing.com - Investing.com Canada

Nov 20, 2024
pulisher
Nov 20, 2024

Ironwood Pharmaceuticals (IRWD) Stock Declines Despite Industry Gains - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates - MSN

Nov 20, 2024
pulisher
Nov 16, 2024

Ironwood Pharmaceuticals, Inc. Announces Resignation of Andrew Davis as Senior Vice President and Chief Business Officer, Effective November 22, 2024 - Marketscreener.com

Nov 16, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires Significant Stake in Ironwood Ph - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $10.40 Consensus PT from Analysts - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

GSA Capital Partners LLP Purchases 232,087 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference - Business Wire

Nov 13, 2024
pulisher
Nov 13, 2024

Ironwood Pharmaceuticals executive resigns - Investing.com India

Nov 13, 2024
pulisher
Nov 12, 2024

Ironwood Pharmaceuticals executive resigns By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 12, 2024

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results and Recent Business Performance - Defense World

Nov 12, 2024
pulisher
Nov 12, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Lowered to “Buy” Rating by StockNews.com - Defense World

Nov 12, 2024
pulisher
Nov 12, 2024

Creative Planning Increases Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Nov 12, 2024
pulisher
Nov 12, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Cut to Buy at StockNews.com - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

What is Leerink Partnrs’ Estimate for IRWD FY2024 Earnings? - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

FY2024 Earnings Forecast for IRWD Issued By Leerink Partnrs - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Robeco Institutional Asset Management B.V. Raises Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Posts Quarterly Earnings Results - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 08, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highli - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... - Yahoo Finance

Nov 08, 2024
pulisher
Nov 07, 2024

Earnings call: Ironwood Pharmaceuticals reports robust LINZESS demand By Investing.com - Investing.com Canada

Nov 07, 2024
pulisher
Nov 07, 2024

Ironwood: Q3 Earnings Snapshot - Houston Chronicle

Nov 07, 2024
pulisher
Nov 07, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap DownTime to Sell? - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Ironwood Pharmaceuticals Q3 Earnings: Revenue Beats at $91.59M, EPS Misses at $0.02 - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results - Business Wire

Nov 07, 2024
pulisher
Nov 07, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... By GuruFocus - Investing.com Canada

Nov 07, 2024
pulisher
Nov 06, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Prev - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

StockNews.com Upgrades Ironwood Pharmaceuticals (NASDAQ:IRWD) to Strong-Buy - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

Ironwood Pharmaceuticals (IRWD) Sees Stock Surge Amid Positive A - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Ironwood Pharmaceuticals Announces Agreement with Teva Involving LINZESS® (linaclotide) 72 mcg Dosage Strength - Marketscreener.com

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Ironwood Pharmaceu - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Upgraded at StockNews.com - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Allspring Global Investments Holdings LLC - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Emerald Advisers LLC Has $1.88 Million Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 04, 2024
pulisher
Oct 31, 2024

Where Are They Now? Ironwood Pharmaceuticals - Life Science Leader Magazine

Oct 31, 2024
pulisher
Oct 31, 2024

Ironwood Pharmaceuticals (IRWD) Scheduled to Post Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 29, 2024

What Do Analysts Think About Ironwood Pharmaceuticals Inc’s (NASDAQ:IRWD) Future? - Stocks Register

Oct 29, 2024
pulisher
Oct 28, 2024

Short Bowel Syndrome Market to Show Remarkable Growth Trends - openPR

Oct 28, 2024
pulisher
Oct 28, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 9.1% HigherHere's What Happened - MarketBeat

Oct 28, 2024

Finanzdaten der Ironwood Pharmaceuticals Inc-Aktie (IRWD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ironwood Pharmaceuticals Inc-Aktie (IRWD) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Emany Sravan Kumar
SVP, COO and CFO
Nov 18 '24
Sale
4.08
11,001
44,884
309,572
$90.52
price up icon 3.66%
$13.36
price down icon 0.30%
$85.69
price up icon 0.28%
$60.98
price up icon 2.21%
$125.65
price up icon 0.52%
$13.37
price up icon 0.91%
Kapitalisierung:     |  Volumen (24h):